Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON

Disc Medicine

Disc Medicine clinical programs — 308 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
Status
Public
HQ
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
Employees
165
Programs
308
Drugs
442
Patents
706
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Disc Medicine projects

308 ClinicalTrials.gov programs sponsored by Disc Medicine.

Disc Medicine has 308 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

308 programs

Clinical programs

Page 4 of 7

  1. NaCl 0 for Subarachnoid hemorrhage

    Disc Medicine

    Subarachnoid hemorrhage

    phase 2 small molecule active

    1 trial

  2. Natriumthiosulfat 25%

    Disc Medicine

    Raynaud’s phenomenon

    phase 2 small molecule active

    1 trial

  3. PEGINTERFERON ALFA-2A for Metastatic Melanoma

    Disc Medicine

    Metastatic Melanoma

    phase 2 small molecule active

    1 trial

  4. Proleukin 18 x 106 IE Poeder voor oplossing voor injectie of infusie

    Disc Medicine

    MDS with excess blasts, MDS/AML or AML patients

    phase 2 small molecule active

    1 trial

  5. RuxoTam; A phase II study to evaluate safety... for Myelofibrosis

    Disc Medicine

    Myelofibrosis

    phase 2 other active

    1 trial

  6. Safety and efficacy of IMM-101 combined with...

    Disc Medicine

    Limited metastatic pancreatic cancer

    phase 2 other active

    1 trial

  7. Skyrizi 600 mg concentrate for solution for infusion

    Disc Medicine

    Inflammatory Bowel Disease (IBD)

    phase 2 small molecule active

    1 trial

  8. Sodium Chloride 0.9% w/v Intravenous Infusion...

    Disc Medicine

    aneurysmal subarachnoid hemorrhage

    phase 2 small molecule active

    1 trial

  9. Softisan 378, Cannabidiol

    Disc Medicine

    psychological disorders: PTSD; Anxiety disorders

    phase 2 small molecule active

    1 trial

  10. TNT-OES-2

    Disc Medicine

    oesophageal cancer, oesophagogastric junction cancer

    phase 2 small molecule active

    1 trial

  11. TOPIRAMATE

    Disc Medicine

    human immunodeficiency virus 1 (HIV-1)

    phase 2 small molecule active

    1 trial

  12. Tecentriq 1 200 mg concentrate for solution for infusion

    Disc Medicine

    (Diffuse) Large B-cell Lymphoma

    phase 2 small molecule active

    1 trial

  13. Tiragolumab for HNSCC, metastatic deficient mis…

    Disc Medicine

    HNSCC, metastatic deficient mismatch repair (dMMR)/MSI-high (MSI-H) tumors, irresectable or metastatic melanoma, locally advanced or metastatic solid tumor

    phase 2 small molecule active

    1 trial

  14. YERVOY for castration-resistant prostate c…

    Disc Medicine

    castration-resistant prostate cancer

    phase 2 small molecule active

    1 trial

  15. Zr89

    Disc Medicine

    giant cell arteritis, rheumatoid arthritis

    phase 2 small molecule active

    1 trial

  16. [18F]Fluor-PEG-Folate

    Disc Medicine

    giant cell arteritis

    phase 2 small molecule active

    1 trial

  17. [18F]Tetrafluoroborate

    Disc Medicine

    Differentiated Thyroid Cancer

    phase 2 small molecule active

    1 trial

  18. [68Ga]FAPI-46

    Disc Medicine

    giant cell arteritis - polymyalgia rheumatica spectrum disease

    phase 2 small molecule active

    1 trial

  19. [68Ga]Ga-PentixaFor

    Disc Medicine

    Cardiac Sarcoidosis

    phase 2 small molecule active

    1 trial

  20. cRGD-ZW800-1

    Disc Medicine

    Squamous cell carcinoma of the larynx and hypopharynx

    phase 2 small molecule active

    1 trial

  21. cRGD-ZW800-1

    Disc Medicine

    Oral cancer

    phase 2 small molecule active

    1 trial

  22. 14341

    Disc Medicine

    Glioma

    phase 1 other active

    1 trial

  23. 17651

    Disc Medicine

    Locally advanced rectal cancer

    phase 1 other active

    1 trial

  24. 2021-003637-11

    Disc Medicine

    Patients with malignant peritoneal mesothelioma

    phase 1 other active

    1 trial

  25. 23U-0502

    Disc Medicine

    Metastatic colorectal cancer

    phase 1 other active

    1 trial

  26. 68GA-FAPI-46

    Disc Medicine

    Peritoneal metastases

    phase 1 small molecule active

    1 trial

  27. A phase I study investigating the local toler... for Tuberculosis

    Disc Medicine

    Tuberculosis

    phase 1 other active

    1 trial

  28. AmBisome liposomale amfotericine B for Chronic pulmonary aspergillosis

    Disc Medicine

    Chronic pulmonary aspergillosis

    phase 1 small molecule active

    1 trial

  29. An open label for High grade serous ovarian cancer

    Disc Medicine

    High grade serous ovarian cancer

    phase 1 other active

    1 trial

  30. Bio-equivalence of Rosuvastatin 10 mg

    Disc Medicine

    Healthy volunteers

    phase 1 other active

    1 trial

  31. Click-cleavable imaging in HER2-positive cancers (CleavHER trial).

    Disc Medicine

    HER2-positive tumors

    phase 1 other active

    1 trial

  32. Coadministration of GA2 Sporozoites With Adjuvants (CoGA)

    Disc Medicine

    Falciparum malaria

    phase 1 other active

    1 trial

  33. DISC-0974

    Disc Medicine

    Chronic Kidney Diseases

    phase 1 small molecule completed

    1 trial

  34. DISC-0974

    Disc Medicine

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  35. DISC-3405

    Disc Medicine

    Sickle Cell Disease

    phase 1 small molecule active

    1 trial

  36. DISC-3405

    Disc Medicine

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  37. Dendritic cell therapy combined with surgery in mesothelioma (ENSURE)

    Disc Medicine

    Adult patients diagnosed with resectable epithelioid MPM, following first-line chemotherapy.

    phase 1 other active

    1 trial

  38. Dual-Wavelength Quantitative Fluorescence End... for Esophageal cancer

    Disc Medicine

    Esophageal cancer

    phase 1 other active

    1 trial

  39. Evaluation of the Novel Therapeutic Hepatitis... for chronic Hepatitis B

    Disc Medicine

    chronic Hepatitis B

    phase 1 other active

    1 trial

  40. GRoningen Early-PD Ambroxol Treatment Pharmacokinetics

    Disc Medicine

    Parkinson's disease

    phase 1 other active

    1 trial

  41. INTERACT stomach

    Disc Medicine

    Stomach Cancer with metastasis in the peritoneum

    phase 1 other active

    1 trial

  42. Improving Peptide Receptor Radionuclide Therapy with PARP inhibitors

    Disc Medicine

    locally advanced or metastatic, well-differentiated gastro-enteropancreatic neuroendocrine tumors.

    phase 1 other active

    1 trial

  43. Irinotecan Accord 20 mg/ml concentraat voor oplossing voor infusie

    Disc Medicine

    Gastric cancer

    phase 1 small molecule active

    1 trial

  44. MCA-derived MSC therapy in renal transplant recipients

    Disc Medicine

    Rejection transplanted kidney, BPAR

    phase 1 other active

    1 trial

  45. Mino-PK

    Disc Medicine

    Nontuberculous mycobacterial disease

    phase 1 other active

    1 trial

  46. Molecular imaging with FAPI for diagnosing the CSM4 colorectal cancer subtype

    Disc Medicine

    Colorectal cancer, liver metastases

    phase 1 other active

    1 trial

  47. NC2022-01

    Disc Medicine

    Glioblastoma

    phase 1 other active

    1 trial

  48. NL202100762

    Disc Medicine

    Patients with stage II-IV high risk diffuse large B-cell lymphoma, defined as international prognostic index > 2, Lymphoma

    phase 1 other active

    1 trial

Frequently asked questions

How many clinical projects does Disc Medicine have?

308 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.